Dr. Sherine Abbas Helmy has 37 years of professional experience in the pharmaceutical industry. Throughout the years, he was appointed as CEO of Pharco Corporation, CEO of Pharco Pharmaceutical International-KSA, board member of Batterjee Pharmaceuticals, KSA; Pharco Impex, Romania; consultant of SEEG Pharm, Switzerland; and Presidio Pharmaceu cals, USA that discovered a new HCV drug.
Dr.Sherine was graduated in 1981 with a Bachelor of Science degree from the Faculty of Pharmacy, Alexandria University. He then obtained an MBA from the Arab Academy for Science and Technology (AAST) and the Central Michigan University in 1999. In 2012, he received his Doctor of Business Administration degree from AAST, which was an additional step towards excelling in the business world.
He is a Board Member of several organizations as, Alexandria University, Faculty of Pharmacy, Azhar University, Scientific Research Committee of Alexandria University, the City Advisory Council Zewail City of Science and Technology, Drug Research Council (Academy of Scientific Research and Technology), Science & Technology Development Fund (STDF), and the Egyptian Exporters Association (Expolink).